(LRCX) Lam Research - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5128073062

Semiconductor, Processing, Equipment, Deposition, Etch

LRCX EPS (Earnings per Share)

EPS (Earnings per Share) of LRCX over the last years for every Quarter: "2020-03": 0.38793304761583, "2020-06": 0.4725898138601, "2020-09": 0.55922729001413, "2020-12": 0.59572955931739, "2021-03": 0.74070147777801, "2021-06": 0.79759256936605, "2021-09": 0.82724034443104, "2021-12": 0.84422383946866, "2022-03": 0.72954439978009, "2022-06": 0.87405666857056, "2022-09": 1.0392098128389, "2022-12": 1.0770997293511, "2023-03": 0.60120979356697, "2023-06": 0.59716128936246, "2023-09": 0.66638481294024, "2023-12": 0.72172591135985, "2024-03": 0.73436791922018, "2024-06": 0.77817591067179, "2024-09": 0.85612538015714, "2024-12": 0.92221958095781, "2025-03": 1.0330463473333, "2025-06": 1.3470463994587,

LRCX Revenue

Revenue of LRCX over the last years for every Quarter: 2020-03: 2503.625, 2020-06: 2791.864, 2020-09: 3177.08, 2020-12: 3456.237, 2021-03: 3847.654, 2021-06: 4145.179, 2021-09: 4304.465, 2021-12: 4226.604, 2022-03: 4060.416, 2022-06: 4635.554, 2022-09: 5074.121, 2022-12: 5277.569, 2023-03: 3869.569, 2023-06: 3207.257, 2023-09: 3482.062, 2023-12: 3758.259, 2024-03: 3793.558, 2024-06: 3871.507, 2024-09: 4167.976, 2024-12: 4376.047, 2025-03: 4720.175, 2025-06: 5171.393,

Description: LRCX Lam Research

Lam Research Corp (NASDAQ:LRCX) is a leading manufacturer of semiconductor processing equipment, offering a range of products for depositing, etching, and cleaning wafers during the fabrication of integrated circuits. The companys product portfolio includes systems for tungsten metallization, copper interconnects, and dielectric film solutions, among others.

From a business perspective, Lam Research Corp has a strong presence in the global semiconductor industry, with a customer base spanning the United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The companys Equipment Intelligence solutions enable repeatable wafer-to-wafer performance, a key factor in the production of high-quality semiconductors.

Analyzing key performance indicators (KPIs), Lam Research Corps market capitalization stands at $130.9 billion, indicating a significant market presence. The companys return on equity (RoE) is 52.74%, suggesting a high level of profitability. Additionally, the forward price-to-earnings (P/E) ratio is 23.09, which is relatively reasonable compared to the industry average.

To further evaluate the companys prospects, we can consider metrics such as revenue growth, gross margin, and operating cash flow. Lam Research Corps revenue growth has been driven by the increasing demand for semiconductor processing equipment, while its gross margin has remained relatively stable due to the companys focus on high-end products. The companys operating cash flow has also been strong, enabling it to invest in research and development and expand its product offerings.

Overall, Lam Research Corps strong product portfolio, global presence, and solid financial performance make it a significant player in the semiconductor industry. Further analysis of the companys KPIs and industry trends can provide valuable insights into its future prospects and potential investment opportunities.

LRCX Stock Overview

Market Cap in USD 146,280m
Sub-Industry Semiconductor Materials & Equipment
IPO / Inception 1984-05-11

LRCX Stock Ratings

Growth Rating 82.4%
Fundamental 85.7%
Dividend Rating 69.3%
Return 12m vs S&P 500 31.9%
Analyst Rating 4.33 of 5

LRCX Dividends

Dividend Yield 12m 1.21%
Yield on Cost 5y 4.09%
Annual Growth 5y 11.91%
Payout Consistency 100.0%
Payout Ratio 23.0%

LRCX Growth Ratios

Growth Correlation 3m 65.5%
Growth Correlation 12m 62.1%
Growth Correlation 5y 74.4%
CAGR 5y 43.89%
CAGR/Max DD 3y 0.93
CAGR/Mean DD 3y 4.73
Sharpe Ratio 12m 1.02
Alpha 41.50
Beta 0.939
Volatility 41.69%
Current Volume 11060.5k
Average Volume 20d 11060.5k
Stop Loss 113 (-3.4%)
Signal 0.71

Piotroski VR‑10 (Strict, 0-10) 9.0

Net Income (5.36b TTM) > 0 and > 6% of Revenue (6% = 1.11b TTM)
FCFTA 0.27 (>2.0%) and ΔFCFTA 4.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 43.12% (prev 57.33%; Δ -14.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.29 (>3.0%) and CFO 6.17b > Net Income 5.36b (YES >=105%, WARN >=100%)
Net Debt (-1.91b) to EBITDA (6.48b) ratio: -0.29 <= 3.0 (WARN <= 3.5)
Current Ratio 2.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (1.28b) change vs 12m ago -2.61% (target <= -2.0% for YES)
Gross Margin 48.71% (prev 47.32%; Δ 1.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 91.97% (prev 79.52%; Δ 12.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 34.19 (EBITDA TTM 6.48b / Interest Expense TTM 178.2m) >= 6 (WARN >= 3)

Altman Z'' 11.56

(A) 0.37 = (Total Current Assets 14.52b - Total Current Liabilities 6.57b) / Total Assets 21.35b
(B) 1.36 = Retained Earnings (Balance) 28.99b / Total Assets 21.35b
warn (B) unusual magnitude: 1.36 — check mapping/units
(C) 0.30 = EBIT TTM 6.09b / Avg Total Assets 20.04b
(D) 2.52 = Book Value of Equity 28.93b / Total Liabilities 11.48b
Total Rating: 11.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 85.72

1. Piotroski 9.0pt = 4.0
2. FCF Yield 3.96% = 1.98
3. FCF Margin 30.99% = 7.50
4. Debt/Equity 0.45 = 2.40
5. Debt/Ebitda 0.69 = 2.14
6. ROIC - WACC 30.22% = 12.50
7. RoE 58.48% = 2.50
8. Rev. Trend 13.22% = 0.66
9. Rev. CAGR 0.69% = 0.09
10. EPS Trend 38.47% = 0.96
11. EPS CAGR 9.89% = 0.99

What is the price of LRCX shares?

As of September 15, 2025, the stock is trading at USD 116.96 with a total of 11,060,492 shares traded.
Over the past week, the price has changed by +11.32%, over one month by +8.92%, over three months by +25.52% and over the past year by +56.00%.

Is Lam Research a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Lam Research (NASDAQ:LRCX) is currently (September 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 85.72 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LRCX is around 139.83 USD . This means that LRCX is currently undervalued and has a potential upside of +19.55% (Margin of Safety).

Is LRCX a buy, sell or hold?

Lam Research has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy LRCX.
  • Strong Buy: 20
  • Buy: 4
  • Hold: 9
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the LRCX price?

Issuer Target Up/Down from current
Wallstreet Target Price 109.1 -6.7%
Analysts Target Price 109.1 -6.7%
ValueRay Target Price 156.9 34.1%

Last update: 2025-09-13 05:03

LRCX Fundamental Data Overview

Market Cap USD = 146.28b (146.28b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 6.39b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 27.8506
P/E Forward = 25.8398
P/S = 7.9347
P/B = 14.8333
P/EG = 1.9189
Beta = 1.77
Revenue TTM = 18.44b USD
EBIT TTM = 6.09b USD
EBITDA TTM = 6.48b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 754.3m USD (from shortTermDebt, last quarter)
Debt = 4.47b USD (Calculated: Short Term 754.3m + Long Term 3.72b)
Net Debt = -1.91b USD (from netDebt column, last quarter)
Enterprise Value = 144.36b USD (146.28b + Debt 4.47b - CCE 6.39b)
Interest Coverage Ratio = 34.19 (Ebit TTM 6.09b / Interest Expense TTM 178.2m)
FCF Yield = 3.96% (FCF TTM 5.71b / Enterprise Value 144.36b)
FCF Margin = 30.99% (FCF TTM 5.71b / Revenue TTM 18.44b)
Net Margin = 29.06% (Net Income TTM 5.36b / Revenue TTM 18.44b)
Gross Margin = 48.71% ((Revenue TTM 18.44b - Cost of Revenue TTM 9.46b) / Revenue TTM)
Tobins Q-Ratio = 4.99 (Enterprise Value 144.36b / Book Value Of Equity 28.93b)
Interest Expense / Debt = 0.96% (Interest Expense 42.8m / Debt 4.47b)
Taxrate = 10.07% (599.9m / 5.96b)
NOPAT = 5.48b (EBIT 6.09b * (1 - 10.07%))
Current Ratio = 2.21 (Total Current Assets 14.52b / Total Current Liabilities 6.57b)
Debt / Equity = 0.45 (Debt 4.47b / last Quarter total Stockholder Equity 9.86b)
Debt / EBITDA = 0.69 (Net Debt -1.91b / EBITDA 6.48b)
Debt / FCF = 0.78 (Debt 4.47b / FCF TTM 5.71b)
Total Stockholder Equity = 9.16b (last 4 quarters mean)
RoA = 25.10% (Net Income 5.36b, Total Assets 21.35b )
RoE = 58.48% (Net Income TTM 5.36b / Total Stockholder Equity 9.16b)
RoCE = 47.30% (Ebit 6.09b / (Equity 9.16b + L.T.Debt 3.72b))
RoIC = 39.44% (NOPAT 5.48b / Invested Capital 13.89b)
WACC = 9.22% (E(146.28b)/V(150.75b) * Re(9.48%)) + (D(4.47b)/V(150.75b) * Rd(0.96%) * (1-Tc(0.10)))
Shares Correlation 3-Years: -100.00 | Cagr: -0.65%
Discount Rate = 9.48% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.65% ; FCFE base≈5.13b ; Y1≈5.60b ; Y5≈7.08b
Fair Price DCF = 75.76 (DCF Value 95.88b / Shares Outstanding 1.27b; 5y FCF grow 10.45% → 3.0% )
Revenue Correlation: 13.22 | Revenue CAGR: 0.69%
Rev Growth-of-Growth: 37.59
EPS Correlation: 38.47 | EPS CAGR: 9.89%
EPS Growth-of-Growth: 50.44

Additional Sources for LRCX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle